BRPI0811293A2 - métodos para a expansão direta de epítopos para uso com ligantes de anticorpo. - Google Patents

métodos para a expansão direta de epítopos para uso com ligantes de anticorpo.

Info

Publication number
BRPI0811293A2
BRPI0811293A2 BRPI0811293A BRPI0811293A BRPI0811293A2 BR PI0811293 A2 BRPI0811293 A2 BR PI0811293A2 BR PI0811293 A BRPI0811293 A BR PI0811293A BR PI0811293 A BRPI0811293 A BR PI0811293A BR PI0811293 A2 BRPI0811293 A2 BR PI0811293A2
Authority
BR
Brazil
Prior art keywords
epitopes
methods
direct expansion
antibody ligands
ligands
Prior art date
Application number
BRPI0811293A
Other languages
English (en)
Inventor
Bonnin Dustan
Original Assignee
Peptimmune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptimmune Inc filed Critical Peptimmune Inc
Publication of BRPI0811293A2 publication Critical patent/BRPI0811293A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BRPI0811293A 2007-05-07 2008-05-07 métodos para a expansão direta de epítopos para uso com ligantes de anticorpo. BRPI0811293A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US92822507P 2007-05-07 2007-05-07
US99928407P 2007-10-16 2007-10-16
US99928307P 2007-10-16 2007-10-16
US12468908P 2008-04-17 2008-04-17
PCT/US2008/005919 WO2009023047A2 (en) 2007-05-07 2008-05-07 Methods for the directed expansion of epitopes for use as antibody ligands

Publications (1)

Publication Number Publication Date
BRPI0811293A2 true BRPI0811293A2 (pt) 2017-05-16

Family

ID=40351332

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0811293A BRPI0811293A2 (pt) 2007-05-07 2008-05-07 métodos para a expansão direta de epítopos para uso com ligantes de anticorpo.

Country Status (11)

Country Link
US (1) US20100298547A1 (pt)
EP (1) EP2157980A2 (pt)
JP (1) JP2010540410A (pt)
KR (1) KR20100019487A (pt)
CN (1) CN101848731A (pt)
AU (1) AU2008287530A1 (pt)
BR (1) BRPI0811293A2 (pt)
CA (1) CA2686817A1 (pt)
IL (1) IL201997A0 (pt)
MX (1) MX2009012085A (pt)
WO (1) WO2009023047A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0817682A2 (pt) * 2007-10-16 2015-04-07 Peptimmune Inc Métodos para projetar e preparar vacinas compreendendo composições de polímero de sequência direcionada via a expansão direta de epítopos
CA2759118A1 (en) 2008-04-17 2009-10-22 Declion Pharmaceuticals, Inc. Design and synthesis of directed sequence polymer compositions and antibodies thereof for the treatment of protein conformational disorders
WO2011056644A2 (en) * 2009-10-28 2011-05-12 Centocor Ortho Biotech Inc. Anti-glp-1r antibodies and their uses
KR101694523B1 (ko) 2015-07-01 2017-01-23 박성진 위험을 알리는 cctv 카메라용 브라켓
CN111363043B (zh) * 2020-04-09 2021-07-23 福州迈新生物技术开发有限公司 抗cd20蛋白单克隆抗体、细胞系及其制备方法和应用
CN112661816B (zh) * 2021-01-13 2022-10-11 江西省人民医院 用于利妥昔单抗血药浓度检测的人工抗原及试剂盒

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859204A (en) * 1992-04-07 1999-01-12 Emory University Modified factor VIII
AU698962B2 (en) * 1993-09-14 1998-11-12 Epimmune, Inc. Alteration of immune response using pan DR-binding peptides
US6093396A (en) * 1996-09-27 2000-07-25 Diamyd Therapeutics Ab Modified glutamic acid decarboxylase (GAD)
FR2765688B1 (fr) * 1997-07-04 1999-09-10 Pasteur Institut Reactif de detection et de suivi des infections provoquees par le virus d'epstein-barr et ses applications
US6541011B2 (en) * 1998-02-11 2003-04-01 Maxygen, Inc. Antigen library immunization
US7118874B2 (en) * 1998-10-09 2006-10-10 Variation Biotechnologies Inc. Immunogenic formulation and process for preparation thereof
IL157073A0 (en) * 2001-01-24 2004-02-08 Harvard College Therapeutic peptides for demyelinating conditions
JP2004085206A (ja) * 2002-08-22 2004-03-18 Ajinomoto Co Inc タンパク質間の相互作用界面情報を用いた疾患関連アミノ酸残基の特定方法およびそれを用いた薬物スクリーニング法
AT412785B (de) * 2003-12-04 2005-07-25 Kungl Andreas J Dr Gag-bindungsproteine
DE102004041964B4 (de) * 2004-08-04 2012-04-26 Schaeffler Technologies Gmbh & Co. Kg Maschinenelement für Wälzbelastung
EP1676859A1 (en) * 2004-12-30 2006-07-05 Pevion Biotech Ltd. Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide
WO2006128294A1 (en) * 2005-06-01 2006-12-07 Variation Biotechnologies Inc. Peptide-based influenza vaccine formulation
US20090162383A1 (en) * 2006-12-26 2009-06-25 Padlan Eduardo A Method for designing vaccines against constantly mutating pathogens

Also Published As

Publication number Publication date
CN101848731A (zh) 2010-09-29
WO2009023047A2 (en) 2009-02-19
CA2686817A1 (en) 2009-02-19
IL201997A0 (en) 2010-06-16
US20100298547A1 (en) 2010-11-25
MX2009012085A (es) 2010-01-20
AU2008287530A1 (en) 2009-02-19
WO2009023047A3 (en) 2009-05-28
KR20100019487A (ko) 2010-02-18
JP2010540410A (ja) 2010-12-24
EP2157980A2 (en) 2010-03-03

Similar Documents

Publication Publication Date Title
CY2019004I2 (el) Τροποποιημενα αντισωματα αντι-ιl-23ρ19
BRPI0808655A2 (pt) anticorpos monoclonais de he4 e métodos para a sua utilização.
BRPI0820543A2 (pt) Anticorpo monoclonal capaz de ligar a anexelekto, e uso do mesmo
CR10705A (es) Anticuerpos para linfotoxina-alfa
BRPI0819165A2 (pt) Anticorpos anti-vegf
NO344963B1 (no) Humanisert antistoff
DK2019840T3 (da) Antagonist anti-human CD40 monoklonalt antistof.
DK1853310T3 (da) Anti-Abeta-antistofpræparat
BRPI0820407A2 (pt) Uso de anticorpos anti-cd40
BRPI0814111A2 (pt) Anticorpo monoclonal citotóxico anticâncer
BRPI0807991A2 (pt) Anticorpos anti-il-23r elaborados.
BRPI0715917A2 (pt) Anticorpos para il-17a
BRPI0923359A2 (pt) Anticorpos anti-igf
CL2014000401A1 (es) Proteina de union a antigeno especifica para el heterodimero alfa4beta7; y composicion que la comprende (div.sol.n°2306-11).
DK2131860T3 (da) Anti-sclerostin-antistoffer
DK3421498T3 (da) Monoklonale antistoffer mod claudin-18 til behandling af cancer
DK2225280T3 (da) Bivalente, bispecifikke antistoffer
BRPI0821405A2 (pt) Anticorpos biespecíficos, bivalentes
BRPI0922885A2 (pt) anticorpos humanos de alta afinidade para a pcsk9.
DK2234600T3 (da) Antistofformulering
DK2044121T3 (da) Glyco-konstruerede antistoffer
BRPI0923231A2 (pt) anticorpo anti-cmet.
BRPI0813626A2 (pt) Epitopos imunogênicos para a imunoterapia
DK2066695T3 (da) Anti-myostatin-antistoffer
BRPI0809677A2 (pt) Anticorpos anti-ige

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]